top of page

Tirzepatide is a similar medication to semaglutide, but is the first dual GIP/GLP-1 receptor co-agonist and has been found in studies to be even more effective with regards to weight loss, glycemic
control and decreased side effects such as nausea and fatigue.

bottom of page


